Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anne C. Bay-Jensen$suffix/text()$suffix/text(), Anne Sofie Siebuhr$suffix/text()$suffix/text(), Dres Damgaard$suffix/text()$suffix/text(), Patryk Drobinski$suffix/text()$suffix/text(), Christian Thudium$suffix/text()$suffix/text(), Joachim Mortensen$suffix/text()$suffix/text() & Claus H Nielsen$suffix/text()$suffix/text(). (2021) Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?. Expert Review of Proteomics 18:3, pages 159-175.
Read now
Read now
Mark Kacar, Sinisa Savic & Jeroen C H van der Hilst. (2020) The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature. Journal of Inflammation Research 13, pages 141-149.
Read now
Read now
Julio Ramírez & Juan D Cañete. (2018) Anakinra for the treatment of rheumatoid arthritis: a safety evaluation. Expert Opinion on Drug Safety 17:7, pages 727-732.
Read now
Read now
Filipe Seguro Paula & José Delgado Alves. (2014) Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis. Biologics: Targets and Therapy 8, pages 1-12.
Read now
Read now
Kalliopi Pafili, Nikolaos Papanas & Efstratios Maltezos. (2014) Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?. Expert Opinion on Investigational Drugs 23:9, pages 1277-1284.
Read now
Read now
Aarat M Patel & Larry W Moreland. (2010) Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy. Drug Design, Development and Therapy 4, pages 263-278.
Read now
Read now